APOLLOHOSP - Fundamental Analysis: Financial Health & Valuation
← Back to ListKey Parameters
⭐ Fundamental Rating: 3.0
✅ Positive
Apollo Hospitals demonstrates consistent revenue growth with a PAT of 382 Cr. this quarter, alongside healthy ROCE and ROE figures. The company's debt-to-equity ratio remains conservative at 0.32, indicating financial stability.
⚠️ Limitation
The high P/E ratio of 85.8 suggests the stock is potentially overvalued relative to its earnings and industry peers. Furthermore, the PEG ratio of 7.24 indicates significant expected growth which might not materialize.
📉 Company Negative News
Recent news highlights the stock hitting fresh record highs in July, but also mentions targets, stop loss levels, and discussions around Q1 FY27 results. The article implies a cautious approach towards further gains.
📈 Company Positive News
None found
🏭 Industry
The healthcare sector is witnessing substantial growth driven by rising healthcare expenditure and increasing awareness of health services. Hospital chains like Apollo Hospitals are capitalizing on this trend through expansion and service diversification, although regulatory changes and competition remain significant factors.
🧾 Conclusion
Considering the current valuation metrics, we recommend an entry zone around 8,400 ₹ – 8,600 ₹ if a correction occurs, offering a margin of safety. Long-term holding guidance focuses on monitoring revenue growth, maintaining healthy profitability margins, and assessing expansion strategies within the healthcare industry. The stock presents moderate upside potential with a caveat regarding valuation sensitivity.